Medicover Yönetim

Yönetim kriter kontrolleri 4/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Fredrik Rågmark

İcra Kurulu Başkanı

€2.7m

Toplam tazminat

CEO maaş yüzdesi	39.2%
CEO görev süresi	27.5yrs
CEO sahipliği	1.0%
Yönetim ortalama görev süresi	3.9yrs
Yönetim Kurulu ortalama görev süresi	15yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Fredrik Rågmark'un ücretlendirmesi Medicover'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Mar 31 2024	n/a	n/a	€22m
Dec 31 2023	€3m	€1m	€18m
Sep 30 2023	n/a	n/a	€8m
Jun 30 2023	n/a	n/a	€6m
Mar 31 2023	n/a	n/a	€1m
Dec 31 2022	€3m	€1m	€12m
Sep 30 2022	n/a	n/a	€37m
Jun 30 2022	n/a	n/a	€59m
Mar 31 2022	n/a	n/a	€88m
Dec 31 2021	€2m	€952k	€102m
Sep 30 2021	n/a	n/a	€93m
Jun 30 2021	n/a	n/a	€90m
Mar 31 2021	n/a	n/a	€52m
Dec 31 2020	€2m	€670k	€26m
Sep 30 2020	n/a	n/a	€14m
Jun 30 2020	n/a	n/a	€4m
Mar 31 2020	n/a	n/a	€16m
Dec 31 2019	€1m	€900k	€23m
Sep 30 2019	n/a	n/a	€19m
Jun 30 2019	n/a	n/a	€19m
Mar 31 2019	n/a	n/a	€20m
Dec 31 2018	€1m	€807k	€22m
Sep 30 2018	n/a	n/a	€28m
Jun 30 2018	n/a	n/a	€26m
Mar 31 2018	n/a	n/a	€23m
Dec 31 2017	€921k	€810k	€19m

Tazminat ve Piyasa: Fredrik 'ın toplam tazminatı ($USD 2.94M ) UK pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 2.69M ).

Tazminat ve Kazançlar: Fredrik 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Fredrik Rågmark (61 yo)

27.5yrs

Görev süresi

€2,707,000

Tazminat

Mr. Fredrik Ragmark serves as the Chief Executive Officer of Medicover AB (publ). Mr. Ragmark has been employed with Medicover since 1996. He serves as Managing Director and Board Member of Kalvskär AB.Fr...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Fredrik Rågmark	CEO & Director	no data	€2.71m	1.04% SEK 317.5m
Joe Ryan	Chief Financial Officer	no data	Veri yok	0.96% SEK 292.8m
Jaroslaw Urbanczyk	Chief Information Officer	4.8yrs	Veri yok	0.0052% SEK 1.6m
Hanna Bjellquist	Head of Investor Relations	no data	Veri yok	Veri yok
Jenny Brandt	General Legal Counsel	no data	Veri yok	0.031% SEK 9.5m
Andrew Vallance-Owen	Chief Marketing Officer	no data	Veri yok	Veri yok
Kamila Skorupinski	Group Chief People Officer	less than a year	Veri yok	Veri yok
John Stubbington	Chief Operating Officer of Healthcare Services	8.4yrs	Veri yok	0.53% SEK 161.3m
Staffan Ternstrom	Chief Operating Officer for Diagnostic Services	3.1yrs	Veri yok	0.033% SEK 10.1m

3.9yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim: MCOVBS 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.9 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Fredrik Rågmark	CEO & Director	27.5yrs	€2.71m	1.04% SEK 317.5m
Robert Jochnick	Independent Director	17.5yrs	€54.60k	1.21% SEK 369.4m
Fredrik Stenmo	Independent Chairman	19.5yrs	€101.50k	4.41% SEK 1.3b
Margareta Nordenvall	Independent Director	23.5yrs	€66.20k	0.060% SEK 18.3m
Arno Bohn	Independent Director	23.5yrs	€63.05k	0.20% SEK 60.9m
Cecil Michael Flemming	Independent Director	9.5yrs	€78.30k	Veri yok
Anne Berner	Independent Director	2.3yrs	€59.85k	Veri yok
Azita Shariati	Independent Director	2.3yrs	€63.05k	0.0015% SEK 448.0k
Peder Jochnick	Independent Director	12.5yrs	€54.60k	2.59% SEK 788.6m
Sonali Chandmal	Independent Director	7.5yrs	€71.45k	0.017% SEK 5.1m

15.0yrs

Ortalama Görev Süresi

60.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: MCOVBS 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 15 yıldır).

Medicover Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Insider recently bought kr1.8m worth of stock

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Recent updates

Medicover AB (publ) to Report First Half, 2025 Results on Jul 24, 2025

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

Dividend of €0.12 announced

Insider recently bought kr1.8m worth of stock

Dividend of €0.12 announced

Full year 2023 earnings released: EPS: €0.12 (vs €0.081 in FY 2022)

Medicover AB (publ) Provides Earnings Guidance for the Financial Year 2025

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Medicover AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Medicover AB (publ), Annual General Meeting, Apr 26, 2024

Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024

Insider recently bought kr242k worth of stock

Full year 2022 earnings released: EPS: €0.081 (vs €0.69 in FY 2021)

Full year 2022 earnings released

Medicover AB (publ) Proposes Dividend for 2022

Investor sentiment improves as stock rises 26%

Medicover AB (publ) to Report Q2, 2023 Results on Jul 26, 2023

Medicover AB (publ) to Report Fiscal Year 2022 Results on Feb 17, 2023

Medicover AB (publ) (OM:MCOV B) acquired Übag Mvz Meindentist Gbr.

Medicover AB (publ) (OM:MCOV B) completed the acquisition of Laurus Medical SRL.

Medicover AB (publ), Annual General Meeting, Apr 27, 2023

Medicover AB (publ) (OM:MCOV B) acquired Konzilijum.

Medicover AB (publ) (OM:MCOV B) signed an agreement to acquire Übag Mvz Meindentist Gbr.

Medicover AB (publ) (OM:MCOV B) acquired Kliniki Terapii Allenort Holding Sp. z o.o.

Medicover AB (Publ) Elects Anne Berner and Azita Shariati as Board Members

Full year 2021 earnings released: EPS: €0.69 (vs €0.18 in FY 2020)

General Legal Counsel recently bought kr518k worth of stock

Now 24% undervalued after recent price drop

Medicover AB (publ) Proposes Dividend for the Financial Year 2021, Expected Payable on 6 May 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

Medicover AB (publ) (OM:MCOV B) acquired an unknown majority stake in Mediplus Clinic.

Chief Financial Officer recently sold kr1.4m worth of stock

Independent Director recently sold kr2.9m worth of stock

Third quarter 2021 earnings released

Insufficient new directors

Medicover AB (publ) (OM:MCOV B) acquired 70% stake in Klinikk Hanne As for €18.2 million.

Medicover AB (publ) (OM:MCOV B) acquired 88.8% stake in Sellmerdiers Aps from Liza Diers and Anette Sellmer for €13.7 million.

Chief Information Officer recently bought kr161k worth of stock

Investor sentiment improved over the past week

First quarter 2021 earnings released

Full year 2020 earnings released: EPS €0.18 (vs €0.17 in FY 2019)

New 90-day high: kr188

Full year 2020 earnings released: EPS €0.17 (vs €0.17 in FY 2019)

Revenue beats expectations

Diagnostic Services COO Benedikt Von Braunmühl Has Decided to Leave Medinova Diagnostic Services Limited

New 90-day high: kr154

Medicover AB (publ) to Report Q1, 2021 Results on Apr 29, 2021

Medicover AB (publ) to Report Q3, 2020 Results on Nov 06, 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş